MYZOMIB 2MG INJECTION
₹4232*
MRP ₹5161
18% off
₹4387*
MRP ₹5161
15% CB
₹774 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
MYZOMIB 2MG INJECTION belongs to a group of anti-cancer medicines used to treat adult patients with multiple myeloma and mantle cell lymphoma who have received at least one prior therapy. Multiple myeloma, also known as myeloma, is a type of bone marrow cancer it affects several areas of the body, such as the spine, skull, pelvis, and ribs. Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin lymphoma (NHL). It develops when B-cells (also called B-lymphocytes) become abnormal. B-cells are white blood cells that fight infection.
MYZOMIB 2MG INJECTION contains 'Bortezomibx' that works by interfering with how proteasomes work, which may cause cancer cells to die and may stop cancer from growing and eventually kills them.
MYZOMIB 2MG INJECTION is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously or IV) or under your skin (subcutaneously or SC). MYZOMIB 2MG INJECTION must not be administered into your spinal fluid (intrathecally). You may experience nausea, diarrhoea, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), peripheral neuropathy (nerves malfunction), fatigue, neuralgia, anaemia, leukopenia, constipation, vomiting, lymphopenia, rash, pyrexia, and anorexia. Most of these side effects of MYZOMIB 2MG INJECTION do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
To treat your condition effectually, continue taking MYZOMIB 2MG INJECTION for as long as your doctor has prescribed. Do not stop the MYZOMIB 2MG INJECTION midway. Talk to your doctor before taking MYZOMIB 2MG INJECTION if you have allergies or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Avoid taking MYZOMIB 2MG INJECTION if you are pregnant or breastfeeding because this MYZOMIB 2MG INJECTION can cause harmful effects on the unborn baby. Both women and men using this MYZOMIB 2MG INJECTION should use birth control to avoid pregnancy.
MYZOMIB 2MG INJECTION contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells. MYZOMIB 2MG INJECTION is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in 18 years or older patients. It can be used alone or together with other medicines.
To treat your condition effectually, continue taking MYZOMIB 2MG INJECTION for as long as your doctor has prescribed. Do not stop the MYZOMIB 2MG INJECTION midway. Talk to your doctor before taking MYZOMIB 2MG INJECTION if you have allergies or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. And also, inform your doctor if you have diabetes because this medicine can affect your blood glucose levels. Your doctor may require close monitoring of your blood glucose levels and change your diabetes medicine dose while being treated with MYZOMIB 2MG INJECTION. Avoid taking MYZOMIB 2MG INJECTION if you are pregnant because this MYZOMIB 2MG INJECTION can cause harmful effects on the unborn baby. Both women and men using this MYZOMIB 2MG INJECTION should use birth control to avoid pregnancy and for at least six months following treatment. Do not breastfeed during treatment with MYZOMIB 2MG INJECTION and four months after your final dose of MYZOMIB 2MG INJECTION.
Drug-Drug Interactions: MYZOMIB 2MG INJECTION interacts with antifungal medication (ketoconazole), HIV medication (ritonavir), antibiotic medication (rifampicin), epilepsy medications (carbamazepine, phenytoin or phenobarbital), depression medication (St. John’s Wort), and oral antidiabetics.
Drug-Food Interactions: No food interaction was found.
Drug-Disease Interactions: Inform your doctor before taking MYZOMIB 2MG INJECTION; it requires close monitoring if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), and hepatic disorders.
Multiple myeloma, also known as myeloma, is a type of bone marrow cancer it affects several areas of the body, such as the spine, skull, pelvis, and ribs.
Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin lymphoma (NHL). It develops when B-cells (also called B-lymphocytes) become abnormal. B-cells are white blood cells that fight infection.
Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking MYZOMIB 2MG INJECTION. It could lead to avoiding unpleasant side effects.
Pregnancy
Unsafe
MYZOMIB 2MG INJECTION should not be used during pregnancy because it causes harm to the fetus (newborn baby). Both women of childbearing potential and men must use an effective contraception method while taking MYZOMIB 2MG INJECTION and at least six months afterwards. Please discuss with your doctor any concerns regarding this.
Breast Feeding
Unsafe
MYZOMIB 2MG INJECTION should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby. It is contraindicated in breastfeeding mothers.
Driving
Caution
MYZOMIB 2MG INJECTION may affect your reactions and your ability to drive. Possible side effects of chemotherapy with MYZOMIB 2MG INJECTION may occur, such as nausea and vomiting. If you are affected by these side effects, you should not drive and/or operate machines that require you to be alert.
Liver
Caution
If you have a history or evidence of liver-related diseases, inform the doctor before prescribing the MYZOMIB 2MG INJECTION. Your doctor will weigh the benefits and potential risks before prescribing them.
Kidney
Caution
If you have a history or evidence of kidney-related diseases, inform the doctor before prescribing the MYZOMIB 2MG INJECTION. Your doctor will weigh the benefits and potential risks before prescribing them.
Children
Unsafe
MYZOMIB 2MG INJECTION should not be used by children below 18 years of age, as efficacy and safety have not been established.
Product Substitutes
We provide you with authentic, trustworthy and relevant information